Clinical trials for covid-19 sars-cov-2

The European Union Clinical Trials Register allows you to search for protocol and results information on:

interventional clinical trials that are conducted in the European Union (EU) and the European Economic Area (EEA);

clinical trials conducted outside the EU / EEA that are linked to European paediatric-medicine development.

Learn more about the EU Clinical Trials Register including the source of the information and the legal basis.

The EU Clinical Trials Register currently displays 39361 clinical trials with a EudraCT protocol, of which 6446 are clinical trials conducted with subjects less than 18 years old.
The register also displays information on 18700 older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

Examples: Cancer AND drug name. Pneumonia AND sponsor name.
How to search [pdf]

Advanced Search:

Search tools

Select Country:	Select Age Range:
Select Trial Status:	Select Trial Phase:
Select Gender:
Select Date Range: to
Select Rare Disease:
IMP with orphan designation in the indication
Orphan Designation Number:
Results Status:
Clear advanced search filters

Trials with a EudraCT protocol (279)
Paediatric studies in scope of Art45 of the Paediatric Regulation (0)

279 result(s) found for: covid-19 sars-cov-2. Displaying page 1 of 14.

EudraCT Number: 2020-001421-31

Sponsor Protocol Number: QUINAVID-19

Start Date*: 2020-04-06

Sponsor Name:Sociedad Española de Farmacia Hospitalaria

Full Title: Clinical trial randomized, unblinded and controled for evaluation of efficacy and safety of hydroxychloroquine chemoprophylaxis against SARS-CoV-2 (COVID-19) infection in healthcare professionals.

Medical condition: SARS-CoV-2 infection

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	10042613 - Surgical and medical procedures	10049924	Infection prophylaxis	PT

Population Age: Adults

Gender: Male, Female

Trial protocol: ES (Ongoing)

Trial results: (No results available)

EudraCT Number: 2020-001587-29

Sponsor Protocol Number: 02/04/2020-001

Start Date*: 2020-04-08

Sponsor Name:Barcelona Institute for Global Health (ISGlobal)

Full Title: Hydroxychloroquine efficacy in preventing SARS-CoV-2 infection and CoVid-19 disease severity during pregnancy

Medical condition: SARS-SoV-2 infection and CoVid-19 disease

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	100000004862	10051905	Coronavirus infection	LLT

Population Age: Adults

Gender: Male

Trial protocol: ES (Ongoing)

Trial results: (No results available)

EudraCT Number: 2021-000206-17	Sponsor Protocol Number: COVID19_7	Start Date*: 2021-03-10
Sponsor Name:Karolinska University Hospital
Full Title: Studies of ongoing and completed SARS-CoV-2 infection (which causes COVID-19) within the healthcare in Stockholm County, with regard to vaccinations.
Medical condition: Vaccination against COVID-19.
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: SE (Ongoing)
Trial results: (No results available)

EudraCT Number: 2021-001107-33

Sponsor Protocol Number: NL76863.068.21

Start Date*: 2021-03-10

Sponsor Name:MUMC

Full Title: SARS-CoV-2 vaccination response in patients with haematological disease

Medical condition: multiple myeloma (including MGUS) chronic lymphocytic leukemia, chronic myeloid leukemia, acute myeloid leukemia, acute lymphocytic leukemia, non-Hodgkin lymphoma, Hodgkin lymphoma, myelodysplastic...

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	21.1	100000004864	10066481	Hematological malignancy	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: NL (Ongoing)

Trial results: (No results available)

EudraCT Number: 2020-001565-37	Sponsor Protocol Number: PrEP_COVID	Start Date*: 2020-04-03
Sponsor Name:ISGlobal
Full Title: PRE-EXPOSURE PROPHYLAXIS WITH HYDROXYCHLOROQUINE FOR HIGH-RISK HEALTHCARE WORKERS DURING THE COVID-19 PANDEMIC (PrEP_COVID): A UNICENTRIC, DOUBLE-BLINDED RANDOMIZED CONTROLLED TRIAL.
Medical condition: COVID-19
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: ES (Ongoing)
Trial results: (No results available)

EudraCT Number: 2021-000842-16

Sponsor Protocol Number: PIRVACoV

Start Date*: 2021-03-18

Sponsor Name:Kristina Jakobsson

Full Title: Does PFAS-exposure modify the risk of COVID-19 infection or the immunological response after vaccination against SARS-CoV-2?

Medical condition: An observational study in healthy, differently PFAS-exposed subjects to check if PFAS modifies the immunological response to SARS-CoV-2 vaccination. The immunological response is quantified as SARS...

Disease:	Version	SOC Term	Classification Code	Term	Level
	23.0	100000004865	10084462	SARS-CoV-2 vaccination	LLT
	23.1	100000004865	10084465	COVID-19 vaccination	LLT

Population Age: Adults

Gender: Male, Female

Trial protocol: SE (Ongoing)

Trial results: (No results available)

EudraCT Number: 2021-001054-57

Sponsor Protocol Number: NL76562.100.21

Start Date*: 2021-03-08

Sponsor Name:OLVG

Full Title: SARS-CoV-2 vaccination response in people living with HIV

Medical condition: COVID-19 vaccine response in people living with HIV

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	23.1	100000004865	10084465	COVID-19 vaccination	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: NL (Ongoing)

Trial results: (No results available)

EudraCT Number: 2020-004066-19

Sponsor Protocol Number: CV-NCOV-005

Start Date*: 2020-12-18

Sponsor Name:CureVac AG

Full Title: COVID-19: A Phase 3, Randomized, Observer-Blinded, Placebo-Controlled Clinical Study Evaluating the Safety and Immunogenicity of Investigational SARS-CoV-2 mRNA Vaccine CVnCoV in Adult Health Care ...

Medical condition: Vaccination for prophylaxis of COVID-19 (healthy adults)

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	23.1	100000004865	10084464	COVID-19 immunization	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Ongoing)

Trial results: (No results available)

EudraCT Number: 2020-003998-22

Sponsor Protocol Number: CV-NCOV-004

Start Date*: 2020-12-11

Sponsor Name:CureVac AG

Full Title: COVID-19: A Phase 2b/3, Randomized, Observer-Blinded, Placebo Controlled, Multicenter Clinical Study Evaluating the Efficacy and Safety of Investigational SARS-CoV-2 mRNA Vaccine CVnCoV in Adults 1...

Medical condition: Vaccination for prophylaxis of COVID-19 (healthy adults)

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	23.1	100000004865	10084464	COVID-19 immunization	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Ongoing) NL (Ongoing)

Trial results: (No results available)

EudraCT Number: 2020-000919-69

Sponsor Protocol Number: 73249

Start Date*: 2020-03-17

Sponsor Name:University Medical Center

Full Title: Reducing health care workers absenteeism in SARS-CoV-2 pandemic by enhanced trained immune responses through Bacillus Calmette-Guérin vaccination, a randomized controlled trial (COVID-19).

Medical condition: SARS-CoV-2 infection

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	100000004848	10047490	Virus identification and serology	HLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: NL (Ongoing)

Trial results: (No results available)

EudraCT Number: 2020-005410-18	Sponsor Protocol Number: 2020/ABM/COVID19/0036	Start Date*: 2020-12-02
Sponsor Name:Samodzielny Publiczny Szpital Kliniczny Nr 1 w Lublinie Samodzielny Publiczny Zakład Opieki Zdrowotnej
Full Title: Multicentre, randomized, double-blind, placebo-controlled, non-commercial clinical trial to evaluate the efficacy and safety of specific anti-SARS-CoV-2 immunoglobulin in the treatment of COVID-19
Medical condition: CoronaVirus Disease 2019
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: PL (Ongoing)
Trial results: (No results available)

EudraCT Number: 2020-004123-16

Sponsor Protocol Number: 2019nCoV-302

Start Date*: 2020-09-23

Sponsor Name:Novavax, Inc.

Full Title: A Phase 3, Randomised, Observer-Blinded, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine (SARS-CoV-2 rS) with Matrix-M1™ ...

Medical condition: Prevention of COVID-19 caused by SARS-CoV-2

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	23.1	100000004865	10084465	COVID-19 vaccination	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (GB - no longer in EU/EEA)

Trial results: (No results available)

EudraCT Number: 2020-001530-35	Sponsor Protocol Number: MeCOVID	Start Date*: 2020-04-09
Sponsor Name:Fundación para la Investigación Biomédica del Hospital La Paz (FIBHULP)
Full Title: Randomized multicenter clinical trial to evaluate the efficacy of melatonin in the prophylaxis of SARS-CoV-2 infection in high-risk contacts. COVID-19
Medical condition: SARS-CoV-2 infection in high-risk contacts
Disease:
Population Age: Adults		Gender: Male, Female
Trial protocol: ES (Ongoing)
Trial results: (No results available)

EudraCT Number: 2020-004272-17

Sponsor Protocol Number: CLO-SCB-2019-003

Start Date*: 2021-03-25

Sponsor Name:Clover Biopharmaceuticals AUS Pty Ltd

Full Title: A Double-Blind, Randomized, Controlled, Phase 2/3 Study to Evaluate the Efficacy, Immunogenicity, and Safety of CpG 1018/Alum-Adjuvanted Recombinant SARS-CoV-2 Trimeric S-protein Subunit Vaccine (S...

Medical condition: SARS-CoV-2-mediated COVID-19

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	23.1	100000004865	10084465	COVID-19 vaccination	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: BE (Ongoing)

Trial results: (No results available)

EudraCT Number: 2020-003654-71

Sponsor Protocol Number: R10933-10987-COV-2069

Start Date*: 2020-10-06

Sponsor Name:Regeneron Pharmaceuticals, Inc.

Full Title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Assessing the Efficacy and Safety of Anti-Spike SARS-CoV-2 Monoclonal Antibodies in Preventing SARS-Cov-2 Infection in Household Contac...

Medical condition: Coronavirus disease 2019 (COVID-19)

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	23.0	10021881 - Infections and infestations	10051905	Coronavirus infection	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: RO (Ongoing) GR (Completed)

Trial results: (No results available)

EudraCT Number: 2020-001385-11

Sponsor Protocol Number: PrEP_COVID_19

Start Date*: 2020-03-28

Sponsor Name:Plan Nacional Sobre SIDA

Full Title: Prevention of SARS-CoV-2 (COVID-19) through Pre-Exposure Prophylaxis with Tenofovir disoproxil/Emtricitabine and Hydroxychloroquine in Healthcare Personnel: Randomized Clinical Trial controlled wit...

Medical condition: COVID-19

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	100000004862	10051905	Coronavirus infection	LLT

Population Age: Adults

Gender: Male, Female

Trial protocol: ES (Ongoing)

Trial results: (No results available)

EudraCT Number: 2020-001357-52

Sponsor Protocol Number: EnCovid-hidroxiCLOROQUINA

Start Date*: 2020-05-13

Sponsor Name:IDIVAL

Full Title: Randomized, Controlled, Double-blind Clinical Trial Comparing the Efficacy and Safety of Chemoprophylaxis With Hydroxychloroquine in Patients Under Biological Treatment and / or JAK Inhibitors in...

Medical condition: Quimioprophylaxis of SARS-CoV-2 infection with hydroxyloquine (HCQ) in patients diagnosed with an immunomediated inflammatory disease who are following a treatment with biological agents and / or J...

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	100000004862	10021982	Inflammatory disorders following infection	HLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: ES (Ongoing)

Trial results: (No results available)

EudraCT Number: 2020-001188-96

Sponsor Protocol Number: 20PH061

Start Date*: 2020-04-07

Sponsor Name:CHU de Saint Etienne

Full Title: Chemoprophylaxis of SARS-CoV-2 infection (COVID-19) in exposed healthcare workers: a randomized double-blind placebo-controlled clinical trial

Medical condition: Healthcare workers

Disease:	Version	SOC Term	Classification Code	Term	Level
	21.1	100000004865	10008434	Chemoprophylaxis NOS	LLT
	20.0	100000004862	10061986	SARS	LLT

Population Age: Adults

Gender: Male, Female

Trial protocol: FR (Ongoing)

Trial results: (No results available)

EudraCT Number: 2020-001936-86

Sponsor Protocol Number: COMET

Start Date*: 2020-10-19

Sponsor Name:Hannover Medical School

Full Title: A prospective, randomized, open label Phase 2 clinical trial to evaluate superiority of anti-SARS-CoV-2 convalescent plasma versus standard-of-care in hospitalized patients with mild COVID-19

Medical condition: Hospitalized patients with mild SARS-CoV-2 infection (WHO R&D Blueprint Ordinal Scale for Clinical Improvement = 3 or 4)

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	23.0	100000004862	10084272	SARS-CoV-2 infection	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Ongoing)

Trial results: (No results available)

EudraCT Number: 2020-001435-27	Sponsor Protocol Number: CHUBX2020/12	Start Date*: 2020-04-10
Sponsor Name:CENTRE HOSPITALIER UNIVERSITAIRE DE BORDEAUX, ETABLISSEMENT PUBLIC
Full Title: Home treatment of elderly patients with symptomatic SARS-CoV-2 infection (COVID-19) : a multiarm, multi-stage (MAMS) randomized trial to assess the efficacy and safety of several experimental treat...
Medical condition: severe acute respiratory syndrome coronavirus 2(SARS-CoV 2)
Disease:
Population Age: Elderly		Gender: Male, Female
Trial protocol: FR (Ongoing)
Trial results: (No results available)

Subscribe to this Search
To subscribe to the RSS feed for this search click here

. This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.

Download Options:
Number of Trials to download:

Download Content:

Download Format:


Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.

Query did not match any studies.

The status of studies in GB is no longer updated from 1.1.2021
For the UK, as from 1.1.2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI
EU Clinical Trials Register Service Desk: https://servicedesk.ema.europa.eu
European Medicines Agency © 1995-2021 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands Legal notice

Austria
Belgium
Bulgaria
Croatia
Cyprus
Czechia
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Outside EU/EEA